on RHÖN-KLINIKUM AG (isin : DE0007042301)
RHÖN-KLINIKUM AG Reports Strong Financial Year Amid Leadership Change
RHÖN-KLINIKUM AG announced a robust financial year, with revenues rising by €131.6 million to €1,595.6 million, driven by increased patient numbers and services. The company treated 912,965 patients, marking a 3.5% growth. Profits and EBITDA also saw improvement, despite rising costs in materials and consumables.
Prof. Dr. Tobias Kaltenbach is set to depart as CEO, marking a strategic shift aligning with the company's merger into the Asklepios Group. The Board will now comprise Dr. Stefan Stranz and Dr. Gunther K. Weiß. Prof. Kaltenbach leaves a legacy of strengthened financial results and strategic partnerships.
Looking forward, RHÖN-KLINIKUM anticipates continuing revenue growth with a focus on sustainability and adapting to regulatory reforms, despite economic uncertainties.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all RHÖN-KLINIKUM AG news